GSTM1 and beta-thalassemia intermedia: The heterozygous state of Hb CS and Hb PS is typically observed without clinical significance, whereas homozygosity for these mutations may be associated with a thalassemia intermedia phenotype, characterized by mild anemia, jaundice, and hepatosplenomegaly (Jomoui et al., 2015).